Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.76 USD | +4.16% | -2.50% | -34.86% |
May. 14 | Sector Update: Health Care Stocks Ease in Tuesday Afternoon Trading | MT |
May. 14 | Pliant Therapeutics Reports Positive Topline Data in Idiopathic Pulmonary Fibrosis Trial | MT |
Evolution of the average Target Price on Pliant Therapeutics, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Pliant Therapeutics, Inc.
Oppenheimer | |
RBC Capital Markets | |
HC Wainwright | |
Canaccord Genuity | |
Cantor Fitzgerald | |
Baird | |
Citigroup | |
JPMorgan Chase | |
SVB Securities LLC | |
Needham & Co. | |
Stifel Nicolaus | |
Piper Sandler | |
Brigantine Advisors |
EPS Revisions
- Stock Market
- Equities
- PLRX Stock
- Consensus Pliant Therapeutics, Inc.